ARGX
Price
$797.35
Change
+$9.41 (+1.19%)
Updated
Oct 7 closing price
Capitalization
48.72B
22 days until earnings call
SLXN
Price
$4.12
Change
+$0.25 (+6.48%)
Updated
Oct 8, 11:45 AM (EDT)
Capitalization
12.07M
Interact to see
Advertisement

ARGX vs SLXN

Header iconARGX vs SLXN Comparison
Open Charts ARGX vs SLXNBanner chart's image
argenx SE
Price$797.35
Change+$9.41 (+1.19%)
Volume$221.77K
Capitalization48.72B
Silexion Therapeutics
Price$4.12
Change+$0.25 (+6.48%)
Volume$1K
Capitalization12.07M
ARGX vs SLXN Comparison Chart in %
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARGX vs. SLXN commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARGX is a StrongBuy and SLXN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 08, 2025
Stock price -- (ARGX: $797.35 vs. SLXN: $3.86)
Brand notoriety: ARGX and SLXN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARGX: 60% vs. SLXN: 12%
Market capitalization -- ARGX: $48.72B vs. SLXN: $12.07M
ARGX [@Biotechnology] is valued at $48.72B. SLXN’s [@Biotechnology] market capitalization is $12.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.19B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARGX’s FA Score shows that 1 FA rating(s) are green whileSLXN’s FA Score has 0 green FA rating(s).

  • ARGX’s FA Score: 1 green, 4 red.
  • SLXN’s FA Score: 0 green, 5 red.
According to our system of comparison, ARGX is a better buy in the long-term than SLXN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARGX’s TA Score shows that 4 TA indicator(s) are bullish while SLXN’s TA Score has 5 bullish TA indicator(s).

  • ARGX’s TA Score: 4 bullish, 4 bearish.
  • SLXN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SLXN is a better buy in the short-term than ARGX.

Price Growth

ARGX (@Biotechnology) experienced а +8.11% price change this week, while SLXN (@Biotechnology) price change was +13.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.19%. For the same industry, the average monthly price growth was +15.97%, and the average quarterly price growth was +89.17%.

Reported Earning Dates

ARGX is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+8.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ARGX($48.7B) has a higher market cap than SLXN($12.1M). ARGX YTD gains are higher at: 29.650 vs. SLXN (-87.197). ARGX has higher annual earnings (EBITDA): 690M vs. SLXN (-17.81M). ARGX has more cash in the bank: 3.93B vs. SLXN (3.47M). SLXN has less debt than ARGX: SLXN (3.7M) vs ARGX (43.2M). ARGX has higher revenues than SLXN: ARGX (3.05B) vs SLXN (0).
ARGXSLXNARGX / SLXN
Capitalization48.7B12.1M402,479%
EBITDA690M-17.81M-3,873%
Gain YTD29.650-87.197-34%
P/E Ratio40.10N/A-
Revenue3.05B0-
Total Cash3.93B3.47M113,329%
Total Debt43.2M3.7M1,168%
FUNDAMENTALS RATINGS
ARGX: Fundamental Ratings
ARGX
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
12
SMR RATING
1..100
38
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARGXSLXN
RSI
ODDS (%)
Bearish Trend 1 day ago
69%
Bullish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
12%
Momentum
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
30%
MACD
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
37%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
28%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
56%
Advances
ODDS (%)
Bullish Trend 6 days ago
69%
Bullish Trend 8 days ago
53%
Declines
ODDS (%)
Bearish Trend 14 days ago
62%
Bearish Trend 1 day ago
78%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
50%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ARGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLXN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
RPAR21.290.11
+0.52%
RPAR Risk Parity ETF
SMAP24.89N/A
N/A
Amplify Small-Mid Cap Equity ETF
IDEC31.20N/A
N/A
Innovator Intl Dev Pwr Bffr ETF - Dec
SHLD70.50-0.57
-0.80%
Global X Defense Tech ETF
WCBR31.33-0.83
-2.58%
WisdomTree Cybersecurity ETF